Sulfachloropyridazine

Sulfachloropyridazine (CAS No.: 80-32-0) is a broad-spectrum sulfonamide antimicrobial agent widely utilized in microbiological and pharmacological research as a model inhibitor of folate biosynthesis in bacteria and certain opportunistic microorganisms. Its primary mechanism of action involves competitive inhibition of dihydropteroate synthase (DHPS), thereby blocking dihydropteroate formation and downstream nucleotide synthesis, ultimately suppressing microbial proliferation. Biochemical studies demonstrate activity against recombinant DHPS in the nanomolar range and inhibitory effects on folate synthesis at low micromolar concentrations, while antimicrobial susceptibility assays indicate strain-dependent minimum inhibitory concentrations typically in the low to high microgram per milliliter range for organisms such as Salmonella species. Sulfachloropyridazine also exhibits activity comparable to related sulfonamides against Pneumocystis species in vitro, supporting its use in mechanistic studies of antifolate resistance and enzyme inhibition. In research settings, it is frequently employed alone or in combination with dihydrofolate reductase inhibitors such as trimethoprim to investigate synergistic interactions in folate pathway blockade, with combination ratios and concentrations adjusted according to experimental design. Additionally, it serves as a representative environmental contaminant in studies of antibiotic persistence and degradation, including advanced oxidation processes. Typical applications include enzyme assays, antimicrobial susceptibility testing, microbial ecology studies, and in vivo infection models in animals, where dosing regimens and exposure levels are selected based on specific experimental objectives.